Portfolio Archive - Page 22 of 60 - Bryan, Garnier & Co

Tombstone_gensight

Bryan, Garnier & Co acts as Joint Bookrunner to GenSight on its EUR 25 million Follow-on Offering

Bryan, Garnier & Co acts as Joint Bookrunner to Targovax on its NOK 75 million Follow-on Offering

McPhy_website_tombstone_4

Bryan, Garnier & Co acts as Sole Financial Advisor, Sole Global Coordinator and Sole Bookrunner to McPhy on a EUR 180m Follow-on Offering including Strategic Investments from Chart Industries and Technip Energies

Innothera_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to INNOTHERA Group on its acquisition of Gibaud

tombstone_sword_argos

Bryan, Garnier & Co acts as Sole Financial Advisor to Sword Group SE on the disposal of its French unit, Sword France, to Argos Wityu

EasyVista_2_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to EasyVista (Euronext: ALEZV) on a contemplated take-private led by Eurazeo PME

website_tombstone_2

Bryan, Garnier & Co acts as Joint Bookrunner on Sensorion’s EUR 31 million Follow-on Offering with top tier US and European biotech specialists and institutional investors

tombstone_humanigen_78200000_dollars

Bryan, Garnier & Co acts as European Lead Manager to Humanigen on its USD 78 million Follow-on Offering

Azelio tombstone 2

Bryan, Garnier & Co acts as Joint Bookrunner to Azelio on its SEK 270 million Follow-on Offering

Innovasjon_AS_website_tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of Innovasjon on the sale of the company to Visolit

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }